Adam Frederik Cohen#

Adam Frederik Cohen
Membership Number:6277
Membership type:ORDINARY
Main Country of Residence:THE NETHERLANDS

Present and Previous Positions
  • 2018 - 2021 Research Director Innovation and Consultancy CHDR,Leiden
  • 1999 - 2011 Vice chairman and chairman of the Netherlands Central Commission for Medical research (CCMO) and Clinical Trial Competent Authority
  • 1993 - 2019 Professor of Clinical Pharmacology, Leiden University Medical Centre
  • 2014 - 2019 Board member of Omnicomm Inc (OMCM Nasdaq). Member of audit committee and governance committee
  • 1987 - 2018 CEO and sole statutory director Foundation Centre for Human Drug Research Leiden
  • 2006 - 2013 CEO of Promasys BV a data management company in Leiden
  • 1984 - 1987 European Project leader, Wellcome Research Laboratories, Beckenham, Kent and Research Registrar Department of Nephrology Dulwich Hospital, London, UK
  • 1984 Senior house officer, Medicine and Nephrology, Dulwich Hospital, London.
  • 1981 - 1984 Department of Clinical Pharmacology,Wellcome Research Laboratories Beckenham, Research physician
  • 1980 - 1981 Pre-Registration clinical training

Fields of Scholarship
  • Education
  • Nephrology and internal medicine
  • Clinical drug research
  • Methodology for evaluating pharmacological action of medicines in man
  • Regulatory and ethical aspects of clinical research
  • Organisation of Clinical Research

Honours and Awards
  • 2021 DDCD Consultancy. Principal consultant
  • 2014 Member of the non-executive board of the Rotterdam Eye Hospital. (2014). Responsible for research and innovation.
  • Chairman and founder of the Paul Janssen FutureLab a new school for scientific entrepeneurs established by the Ministry of Health of the Netherlands in association with Leiden University.
  • Member of the scientific advisory board of the Netherlands Diabetes Patients Association
  • Member of the Scientific Advisory Board of the German Aerospace Research Labs (DLR) Cologne
  • Member of the Scientific Advisory Board of FACIO BV (NL)
  • Member of the Review Board of the Swiss Nazional Fund (SNF) clinical trials program
  • Scientific Advisory Board of the Drug Clinical Trial Center Peking University Third Hospital, Beijing, P.R.China
  • Senior Advisor to the Board of the Foundation CHDR Leiden the Netherlands
  • Officer in the Royal Order of Orange Nassau
  • Fellowship of the Faculty of Pharmaceutical Medicine of the Royal College of Medicine of the UK (FFPM)
  • 2009 Fellowship of the American College of Clinical Pharmacology (FCP)
  • Fellowship of the British Pharmacological Society (FBPhS)
  • Lilly Prize 2017 of the British Pharmacological Society
  • 2021 Saal van Zwanenburg prize of the Royal Holland Society for Sciences (KHMVW) for drug development and entrepreneurship

Imprint Privacy policy « This page (revision-6) was last changed on Tuesday, 19. July 2022, 12:14 by Kaiser Dana
  • operated by